Bulletin
Investor Alert

ADC Therapeutics S.A.

NYS: ADCT

GO
/marketstate/country/us

After Hours

/zigman2/quotes/214411413/composite

$

5.03

Change

-0.02 -0.40%

Volume

Volume 2,623

Jan 27, 2023, 7:45 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/214411413/composite

Previous close

$ 4.72

$ 5.05

Change

+0.33 +6.99%

Day low

Day high

$4.64

$5.07

Open
Open: 4.70

52 week low

52 week high

$2.69

$17.89

Open

Market cap

$388.40M

Average volume

946,669

P/E ratio

N/A

Rev. per Employee

$503,590

EPS

-2.15

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/adct

MarketWatch News on ADCT

  1. ADC Therapeutics started at hold with $42 stock price target at Stifel Nicolaus

    8:00 a.m. Dec. 3, 2020

    - Tomi Kilgore

  2. ADC Therapeutics stock soars 56% in trading debut

    11:05 a.m. May 15, 2020

    - Ciara Linnane

  3. ADC Therapeutics stock soars 52% in trading debut

    11:02 a.m. May 15, 2020

    - Ciara Linnane

  4. ADC Therapeutics sets IPO terms to raise up to $185.3 million

    5:48 a.m. May 14, 2020

    - Tomi Kilgore

  5. ADC Therapeutics sets IPO terms, to offer 8.1 mln shares priced at $23 to $26 each

    6:13 a.m. Sept. 23, 2019

    - Ciara Linnane

/news/nonmarketwatch/company/us/adct

Other News on ADCT

  1. FDA Takes Tougher Line on Fast-Tracked Drugs

    2:34 a.m. Dec. 6, 2022

    - The Wall Street Journal Interactive Edition

  2. ADC Therapeutics SA (ADCT) Q3 2022 Earnings Call Transcript

    9:19 p.m. Nov. 8, 2022

    - Seeking Alpha

  3. Vertex (VRTX) to Report Q3 Earnings: What's in the Cards?

    12:34 p.m. Oct. 25, 2022

    - Zacks.com

  4. ADC Therapeutics SA (ADCT) Q2 2022 Earnings Call Transcript

    11:01 p.m. Aug. 9, 2022

    - Motley Fool

  5. Loading more headlines...
/news/pressrelease/company/us/adct

Press Releases on ADCT

  1. ADC Therapeutics Appoints Mohamed Zaki as Chief Medical Officer

    4:30 p.m. Jan. 3, 2023

    - BusinessWire - BZX

  2. ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer

    7:15 a.m. Dec. 19, 2022

    - BusinessWire - BZX

  3. Biocytogen Enters into Antibody Agreement with ADC Therapeutics

    9:47 a.m. Nov. 28, 2022

    - BusinessWire - BZX

  4. Biocytogen Enters into Antibody Agreement with ADC Therapeutics

    7:00 p.m. Nov. 27, 2022

    - BusinessWire - BZX

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.